Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SLC13A3 | Q8WWT9 | 1/20 | 0.35 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.35 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.33 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.33 |
| ▸ | ACLY | P53396 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.31 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.31 |
| ▸ | FEN1 | P39748 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3230536 | 0.97 | OR51E2 (0.40) | OR51E2MAPK1SLC13A3EGLN1TET2 | |
| SCHEMBL22207784 | 0.74 | — | — | |
| SCHEMBL22207785 | 0.74 | — | — | |
| SCHEMBL1791642 | 0.73 | TET2 (0.34) | TET2ACLY | |
| SCHEMBL1791640 | 0.73 | TET2 (0.34) | TET2ACLY | |
| SCHEMBL23927231 | 0.73 | CA4 (0.32) | CA4 | |
| SCHEMBL9140826 | 0.73 | TET2 (0.34) | TET2ACLY | |
| SCHEMBL3955843 | 0.72 | OR51E2 (0.35) | OR51E2MAPK1SLC13A3EGLN1TET2 | |
| SCHEMBL185832 | 0.71 | — | — | |
| SCHEMBL4444683 | 0.71 | CES1 (0.36) | CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11840522-B2 | Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) | TOSOH CORPORATION (JP) | 2023-12-12 | — | — | US | disclosed |
| US-20220056006-A1 | METHOD OF STABILIZING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) AND COMPOSITION CONTAINING STABILIZED PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) | TOSOH CORPORATION (JP) | 2022-02-24 | — | — | US | disclosed |
| EP-3901144-A1 | METHOD FOR STABILIZING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE)-CONTAINING COMPOSITION AND STABILIZED PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE)-CONTAINING COMPOSITION | Tosoh Corporation (JP) | 2021-10-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11840522-B2 | Method of stabilizing perfluoro(2-methylene-4-methyl-1,3-dioxolane) and composition containing stabilized perfluoro(2-methylene-4-methyl-1,3-dioxolane) | FFAR4, AFF4, PYM1 | OR51E2 529/4885MAPK1 2743/4885SLC13A3 3019/4885 |
| US-20220056006-A1 | METHOD OF STABILIZING PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) AND COMPOSITION CONTAINING STABILIZED PERFLUORO(2-METHYLENE-4-METHYL-1,3-DIOXOLANE) | FFAR4, AFF4, PYM1 | OR51E2 529/4885MAPK1 2743/4885SLC13A3 3019/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.